Global Tumor Ablation Market

  • Report Code : VMI235766
  • Pages : 148
  • Published On : Dec 2018
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 3,950
Multi User License: US$ 4,750
Corporate User License: US$ 6,750
The global Tumor Ablation Marketwas valued at USD 327.46 million in 2016 and is projected to reach USD 915.38 million by 2025, growing at a CAGR of 12.1% from 2017 to 2025.

It is an image-guided technique that uses heat to destroy cancer cells. It uses imaging techniques such as ultrasound, computed tomography (CT) or magnetic resonance imaging (MRI) to help guide a needle electrode into a cancerous tumor. The treatment needs for cancer is increasing with rising number of tumor and cancer patients, the market is growing and expanding currently all over the globe.

Sample Infographics:



Market Dynamics:
1. Market Drivers
1.1 Increasing Cancer Patients all over the globe
1.2 GrowingGeriatric Population
1.3 Technological development
1.4 Increasing number of hospitals and healthcare centers

2. Market Restraints
2.1 High cost of treatment procedures
2.2 Healthcare regulations in the U.S.

Market Segmentation:
1. Global Tumor Ablation Market, by Mode of Treatment:
1.1 Surgical Ablation
1.2 Laparoscopic Ablation
1.3 Percutaneous Ablation

2. Global Tumor Ablation Market, by Application:
2.1 Liver Cancer
2.2 Lung Cancer
2.3 Kidney Cancer
2.4 Bone Metastasis
2.5 Others

3. Global Tumor Ablation Market, by Technology:
3.1 Radiofrequency (RF) Ablation
3.2 Microwave Ablation
3.3 Cryoablation
3.4 Other Technologies

4. Global Tumor Ablation Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa

Competitive Landscape:
The major players in the market are as follows:
1. Medtronic, PLC.
2. Angiodynamics, Inc.
3. Healthtronics, Inc.
4. Galil Medical, Inc.
5. Boston Scientific Corporation
6. Neuwave Medical, Inc.
7. EdapTms S.A.
8. Mermaid Medical A/S
9. Sonacare Medical, LLC
10. Misonix, Inc.

These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Tumor Ablation Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.

To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL TUMOR ABLATION MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL TUMOR ABLATION MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL TUMOR ABLATION MARKET, BY MODE OF TREATMENT
5.1 Surgical Ablation
5.2 Laparoscopic Ablation
5.3 Percutaneous Ablation

6 GLOBAL TUMOR ABLATION MARKET, BY APPLICATION
6.1 Liver Cancer
6.2 Lung Cancer
6.3 Kidney Cancer
6.4 Bone Metastasis
6.5 Others

7 GLOBAL TUMOR ABLATION MARKET, BY TECHNOLOGY
7.1 Radiofrequency (RF) Ablation
7.2 Microwave Ablation
7.3 Cryoablation
7.4 Other Technologies

8 GLOBAL TUMOR ABLATION MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025

9 GLOBAL TUMOR ABLATION MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies

10 COMPANY PROFILES
10.1 Medtronic, PLC.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments

10.2 Angiodynamics, Inc.
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments

10.3 Healthtronics, Inc.
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments

10.4 Galil Medical, Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments

10.5 Boston Scientific Corporation
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments

10.6 Neuwave Medical, Inc.
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments

10.7 EdapTms S.A.
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments

10.8 Mermaid Medical A/S
10.8.1 Overview
10.8.2 Financial Performance
10.8.3 Product Outlook
10.8.4 Key Developments

10.9 Sonacare Medical, LLC
10.9.1 Overview
10.9.2 Financial Performance
10.9.3 Product Outlook
10.9.4 Key Developments

10.10 Misonix, Inc.
10.10.1 Overview
10.10.2 Financial Performance
10.10.3 Product Outlook
10.10.4 Key Developments

11 Appendix
11.1 Related Reports

Tumor-Infiltrating Lymphocyte Therapy Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Tumor-Infiltrating Lymphocyte Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscap...

Focused Ultrasound Ablation Surgery Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Focused Ultrasound Ablation Surgery Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape,...

Tenosynovial Giant Cell Tumor Treatment Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Tenosynovial Giant Cell Tumor Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landsc...

Circulating Tumor Cell Kit Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Circulating Tumor Cell Kit Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...

Tumor Immune Cell Therapy Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Tumor Immune Cell Therapy Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufactu...

Tumor Registry Software Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Tumor Registry Software Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufacture...

Global Cell-Free Circulating Tumor DNA (ctDNA) Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Cell-Free Circulating Tumor DNA (ctDNA) Market: The report discusses everything a marketer requires before investing in the global Cell-Free Circulating Tumor DNA (ctDNA) Market during the for...

Global Minimally Invasive Tumor Treatment Technology Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Minimally Invasive Tumor Treatment Technology Market: The report discusses everything a marketer requires before investing in the global Minimally Invasive Tumor Treatment Technology Market du...

Global Advanced Tumor Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Advanced Tumor Tracking System Market: The report discusses everything a marketer requires before investing in the global Advanced Tumor Tracking System Market during the forecast period 2023-...

2023-2028 Global and Regional Tumor Immunotherapy Industry Status and Prospects Professional Market Research Report Standard Version...

The global Tumor Immunotherapy market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...